semaglutide compounding news november 2025 Compounded is not the same as FDA-approved. The FDA has documented dosing errors and hospitalizations linked to these products. Dr. Jen Ashton breaks down the risks. Always consult your physician before Societies take stand against off-brand

For bodybuilders who decide the risk-benefit calculation favors proceeding, minimum safety precautions include: verifying third-party purity testing for every batch, starting at the lowest possible dose to gauge authenticity and potency, having a trusted healthcare provider aware of your protocol, and monitoring bloodwork regularly throughout the cycle

Track your experiences and discuss them with your healthcare provider to tailor your GLP-1 therapy

Many may be marketed using language that may mislead consumers and violate FDA and FTC advertising rules

In iGlarLixi (insulin glargine: LIXI = 1:1) study, adult Japanese patients with T2DM lost more weight compared to the iGlar (insulin glargine U100) study (-0.51 kg vs

(2) Designing specialized trials targeting special subgroups (e.g., older adults with a long disease duration, patients with comorbid complex diseases) to fill the current evidence gaps